esTOCma, an App Used by Teachers: an RCT
Key facts
- Who runs it
- University of Valencia
- Where
- Spain1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 175 people enrolled
- Started
- 26 Feb 2024
- Ended
- 30 Jun 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Use of esTOCma
- Record updated
- 30 December 2025
Who can take part
- Age
- 18 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Being a practising teacher in non-university education
- Working in the education field as a guidance counsellor, language teacher or therapeutic pedagogue
Who cannot take part
- Having less than 18 years old
- Working in a field other than those mentioned above
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of the present study is to assess the efficacy of a mobile application called esTOCma in promoting mental health literacy, reducing stigmatizing attitudes related to the Obsessive-Compulsive Disorder (OCD) and improving teachers' confidence in dealing with students that might have OCD. A parallel, randomized controlled trial with two conditions (experimental and control group) will be carried out in a sample of teachers that work in primary and secondary education. Pre-post changes will be assessed. Experimental group will use the app until they finish it (within a set period of 10 days), whereas control group will do nothing for 10 days. Primarily, it is expected that after the use of the app, participants will show an improvement in OCD-related literacy, stigmatizing attitudes, desired social distance and their comfort, confidence and perceived ability in teaching and handling students with OCD. Secondarily, the investigators hypothesize that experimental group might show a reduction in obsessive-compulsive symptoms.
The 2 groups in the trial
- Use of esTOCmaTreatment being tested
Experimental group will use esTOCma until they finish it (within a preestablished 10-days period).
- Control groupNo study treatment, for comparison
Control group will do nothing for 10 days.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A RCT of a Mobile App (esTOCma) to Improve Mental Health Literacy, Stigmatizing Attitudes Related to OCD, and Confidence in Dealing With Students With OCD in Teachers
- Record updated
- 30 December 2025